Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(2,4-dichlorophenyl)-5-bromo-2-nitropyrazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

345629-31-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 345629-31-4 Structure
  • Basic information

    1. Product Name: 3-(2,4-dichlorophenyl)-5-bromo-2-nitropyrazine
    2. Synonyms: 3-(2,4-dichlorophenyl)-5-bromo-2-nitropyrazine
    3. CAS NO:345629-31-4
    4. Molecular Formula:
    5. Molecular Weight: 348.971
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 345629-31-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(2,4-dichlorophenyl)-5-bromo-2-nitropyrazine(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(2,4-dichlorophenyl)-5-bromo-2-nitropyrazine(345629-31-4)
    11. EPA Substance Registry System: 3-(2,4-dichlorophenyl)-5-bromo-2-nitropyrazine(345629-31-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 345629-31-4(Hazardous Substances Data)

345629-31-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 345629-31-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,5,6,2 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 345629-31:
(8*3)+(7*4)+(6*5)+(5*6)+(4*2)+(3*9)+(2*3)+(1*1)=154
154 % 10 = 4
So 345629-31-4 is a valid CAS Registry Number.

345629-31-4Upstream product

345629-31-4Downstream Products

345629-31-4Relevant articles and documents

Pyrazine based inhibitors of glycogen synthase kinase 3

-

, (2008/06/13)

New bicyclic based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 345629-31-4